Collegium Pharmaceutical, Inc. Investment Income, Net
Collegium Pharmaceutical, Inc. (COLL) reported Investment Income, Net of $2.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. investment income, net for the quarter ending 2026-06-30 was $2.29M, a 3.94% decline year-over-year.
- Collegium Pharmaceutical, Inc. investment income, net for the quarter ending 2026-03-31 was $3.71M, a 66.56% increase year-over-year.
- Collegium Pharmaceutical, Inc. investment income, net for the quarter ending 2025-12-31 was $3.56M, a 96.74% increase year-over-year.
- Collegium Pharmaceutical, Inc. investment income, net for the quarter ending 2025-09-30 was $3.12M, a 5.00% decline year-over-year.
- Collegium Pharmaceutical, Inc. investment income, net for fiscal 2025 was $11.29M, a 19.23% decline from fiscal 2024.
- Collegium Pharmaceutical, Inc. investment income, net for fiscal 2024 was $13.98M, a 10.50% decline from fiscal 2023.
- Collegium Pharmaceutical, Inc. investment income, net for fiscal 2023 was $15.62M, a 1391.40% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. investment income, net for fiscal 2022 was $1.05M, a 8625.00% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.29M 10-Q · filed 2026-08-06 | $6.00M 10-Q · filed 2026-08-06 | $9.56M derived: sum of 3 quarters · filed 2026-08-06 | $12.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.71M 10-Q · filed 2026-05-07 | $7.27M derived: sum of 2 quarters · filed 2026-05-07 | $10.39M derived: sum of 3 quarters · filed 2026-05-07 | $12.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.56M 10-K · filed 2026-02-26 | $6.68M derived: sum of 2 quarters · filed 2026-02-26 | $9.06M derived: sum of 3 quarters · filed 2026-08-06 | $11.29M 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.12M 10-K · filed 2026-02-26 | $5.50M derived: sum of 2 quarters · filed 2026-08-06 | $7.72M derived: sum of 3 quarters · filed 2026-08-06 | $9.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.38M 10-Q · filed 2026-08-06 | $4.61M 10-Q · filed 2026-08-06 | $6.42M derived: sum of 3 quarters · filed 2026-08-06 | $9.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.23M 10-Q · filed 2026-05-07 | $4.04M derived: sum of 2 quarters · filed 2026-05-07 | $7.32M derived: sum of 3 quarters · filed 2026-05-07 | $11.71M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.81M 10-K · filed 2026-02-26 | $5.09M derived: sum of 2 quarters · filed 2026-02-26 | $9.49M derived: sum of 3 quarters · filed 2026-02-26 | $13.98M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.28M 10-K · filed 2026-02-26 | $7.68M derived: sum of 2 quarters · filed 2026-02-26 | $12.16M 10-Q · filed 2024-11-07 | $16.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.40M 10-K · filed 2026-02-26 | $8.88M 10-Q · filed 2024-08-08 | $13.19M derived: sum of 3 quarters · filed 2026-02-26 | $17.73M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.49M 10-K · filed 2026-02-26 | $8.79M derived: sum of 2 quarters · filed 2026-02-26 | $13.33M derived: sum of 3 quarters · filed 2026-02-26 | $17.36M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.30M 10-K · filed 2025-02-27 | $8.84M derived: sum of 2 quarters · filed 2025-02-27 | $12.87M derived: sum of 3 quarters · filed 2025-02-27 | $15.62M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.54M 10-K · filed 2025-02-27 | $8.56M derived: sum of 2 quarters · filed 2025-02-27 | $11.31M 10-Q · filed 2024-11-07 | $12.34M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $4.03M 10-K · filed 2025-02-27 | $6.77M 10-Q · filed 2024-08-08 | $7.80M derived: sum of 3 quarters · filed 2025-02-27 | $7.81M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.75M 10-K · filed 2025-02-27 | $3.77M derived: sum of 2 quarters · filed 2025-02-27 | $3.79M derived: sum of 3 quarters · filed 2025-02-27 | $3.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.03M 10-K · filed 2024-02-22 | $1.04M derived: sum of 2 quarters · filed 2024-02-22 | $1.04M derived: sum of 3 quarters · filed 2024-02-22 | $1.05M 10-K · filed 2025-02-27 |
| 2022-09-30 | $11.00K 10-K · filed 2024-02-22 | $16.00K derived: sum of 2 quarters · filed 2024-02-22 | $20.00K 10-Q · filed 2023-11-07 | $23.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $5.00K 10-K · filed 2024-02-22 | $9.00K 10-Q · filed 2023-08-03 | $12.00K derived: sum of 3 quarters · filed 2024-02-22 | $15.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $4.00K 10-K · filed 2024-02-22 | $7.00K derived: sum of 2 quarters · filed 2024-02-22 | $10.00K derived: sum of 3 quarters · filed 2024-02-22 | $13.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $3.00K 10-K · filed 2023-02-23 | $6.00K derived: sum of 2 quarters · filed 2023-02-23 | $9.00K derived: sum of 3 quarters · filed 2023-02-23 | $12.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $3.00K 10-K · filed 2023-02-23 | $6.00K derived: sum of 2 quarters · filed 2023-02-23 | $9.00K 10-Q · filed 2022-11-03 | $12.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $3.00K 10-K · filed 2023-02-23 | $6.00K 10-Q · filed 2022-08-04 | $9.00K derived: sum of 3 quarters · filed 2023-02-23 | $12.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $3.00K 10-K · filed 2023-02-23 | $6.00K derived: sum of 2 quarters · filed 2023-02-23 | $9.00K derived: sum of 3 quarters · filed 2023-02-23 | $23.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $3.00K 10-K · filed 2022-02-24 | $6.00K derived: sum of 2 quarters · filed 2022-02-24 | $20.00K derived: sum of 3 quarters · filed 2022-02-24 | $232.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $3.00K 10-K · filed 2022-02-24 | $17.00K derived: sum of 2 quarters · filed 2022-02-24 | $229.00K 10-Q · filed 2021-11-04 | $612.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $14.00K 10-K · filed 2022-02-24 | $226.00K 10-Q · filed 2021-08-05 | $609.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.10M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $212.00K 10-K · filed 2022-02-24 | $595.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.09M derived: sum of 3 quarters · filed 2022-02-24 | $1.62M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $383.00K 10-K · filed 2021-02-25 | $877.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.41M derived: sum of 3 quarters · filed 2021-02-25 | $1.94M 10-K · filed 2022-02-24 |
| 2019-09-30 | $494.00K 10-K · filed 2021-02-25 | $1.03M derived: sum of 2 quarters · filed 2021-02-25 | $1.55M 10-Q · filed 2020-11-05 | $2.04M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $532.00K 10-K · filed 2021-02-25 | $1.06M 10-Q · filed 2020-08-05 | $1.55M derived: sum of 3 quarters · filed 2021-02-25 | $2.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $526.00K 10-K · filed 2021-02-25 | $1.01M derived: sum of 2 quarters · filed 2021-02-25 | $1.57M derived: sum of 3 quarters · filed 2021-02-25 | $1.96M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $489.00K 10-K · filed 2020-02-27 | $1.04M derived: sum of 2 quarters · filed 2020-02-27 | $1.43M derived: sum of 3 quarters · filed 2020-02-27 | $1.69M 10-K · filed 2021-02-25 |
| 2018-09-30 | $552.00K 10-K · filed 2020-02-27 | $943.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.20M 10-Q · filed 2019-11-06 | $1.38M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $391.00K 10-K · filed 2020-02-27 | $646.00K 10-Q · filed 2019-08-07 | $826.00K derived: sum of 3 quarters · filed 2020-02-27 | $993.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $255.00K 10-K · filed 2020-02-27 | $435.00K derived: sum of 2 quarters · filed 2020-02-27 | $602.00K derived: sum of 3 quarters · filed 2020-02-27 | $739.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $180.00K 10-K · filed 2019-02-27 | $347.00K derived: sum of 2 quarters · filed 2019-02-27 | $484.00K derived: sum of 3 quarters · filed 2019-02-27 | $582.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $167.00K 10-K · filed 2019-02-27 | $304.00K derived: sum of 2 quarters · filed 2019-02-27 | $402.00K 10-Q · filed 2018-11-08 | $421.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $137.00K 10-K · filed 2019-02-27 | $235.00K 10-Q · filed 2018-08-08 | $254.00K derived: sum of 3 quarters · filed 2019-02-27 | $252.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $98.00K 10-K · filed 2019-02-27 | $117.00K derived: sum of 2 quarters · filed 2019-02-27 | $115.00K derived: sum of 3 quarters · filed 2019-02-27 | $69.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $17.00K derived: sum of 2 quarters · filed 2018-03-07 | -$29.00K derived: sum of 3 quarters · filed 2018-03-07 | -$94.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | -$2.00K 10-Q · filed 2017-11-08 | -$48.00K derived: sum of 2 quarters · filed 2017-11-08 | -$113.00K 10-Q · filed 2017-11-08 | |
| 2016-06-30 | -$46.00K 10-Q · filed 2017-08-09 | -$111.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$66.00K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | -$439.00K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |